#lung — Thursday, August 13, 2026 (1 items)
| 1 | 💬 0 |
SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial.
(linkinghub.elsevier.com)
|
Cancer Cell 2026-08-13 | #cancer #lung #clinical trial #immunotherapy #toxicity |